Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03644472 · ClinicalTrials.gov registry record · Phase 2
Postmenopausal Women and Their Endothelium
A Phase 2 study of Postmenopausal Women, sponsored by Penn State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 37
- Enrollment target
- 1
- Study location
NCT03644472: Completed Phase 2 study of Postmenopausal Women, sponsored by Penn State University.
NCT03644472 is a Phase 2 study of Postmenopausal Women that has completed, run by Penn State University. The registered enrollment target is 37 participants, below the 91-participant average among 4 other Postmenopausal Women trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03644472, a Phase 2 study of Postmenopausal Women, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test the effects of a one time dose and 7-days of inorganic nitrate (supplied in the form of beetroot juice) on blood vessel function and resting blood pressure in healthy, postmenopausal women. Participants will drink beetroot juice and a placebo juice on separate visits where blood pressure and blood vessel function will be measured.
Primary Outcome
Using near-infrared spectroscopy, a probe placed on the forearm muscle will be used to measure the tissue saturation index re-perfusion slope following 5 minutes of forearm cuff occlusion.
Conditions Studied
Interventions
- DRUG nitrate rich beetroot juice
- DRUG nitrate depleted beetroot juice
Study Locations (1)
Pennsylvania
- Penn State University - University Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2018-11-07 |
| Est. Completion | 2023-02-20 |
| Phase | Phase 2 |
What the finished NCT03644472 record still lists
NCT03644472 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 91-participant average among 4 other Postmenopausal Women trials with a reported enrollment target (59% lower).
The record links to 1 condition, with Postmenopausal Women appearing as the primary indexed condition, and to 2 interventions - of which nitrate rich beetroot juice is the first listed.
NCT03644472 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03644472 about?
NCT03644472 is a clinical study titled "Postmenopausal Women and Their Endothelium". The purpose of this study is to test the effects of a one time dose and 7-days of inorganic nitrate (supplied in the form of beetroot juice) on blood vessel function and resting blood pressure in healthy, postmenopausal women. Participants will drink beetroot juice and a placebo juice on separate vi...
What is the current status of trial NCT03644472?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 37 participants. The study started on 2018-11-07. Estimated completion is 2023-02-20.
What conditions does trial NCT03644472 study?
This clinical trial studies the following conditions: Postmenopausal Women.
What interventions are being tested in trial NCT03644472?
The interventions under investigation include: nitrate rich beetroot juice (DRUG), nitrate depleted beetroot juice (DRUG).
Who is sponsoring clinical trial NCT03644472?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03644472 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postmenopausal Women
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assess the Safety, Efficacy, and Pharmacokinetics of Immediate and Delayed Release Weekly Risedronate
COMPLETED · Phase 2
-
Tocotrienols for Obesity of Postmenopausal Women
ACTIVE NOT RECRUITING · Phase 1
-
Soy Nuts and Cardiovascular Risk in Postmenopausal Women
COMPLETED · NA
-
Vitamin D Deficiency: Bone Loss and Vascular Dysfunction
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI